Three very different people with three very different concerns all turned out to have neurodegenerative disorders of their frontal and temporal lobes. Frontotemporal dementia (FTD) includes several different clinical syndromes: clusters of symptoms often seen together, and these syndromes express brain changes due to multiple different causes. Although the syndromes of FTD differ clinically, they are linked together because they reflect different functions of the frontal and temporal lobes: behavior regulation, language, and muscle control.
FTDs are believed to account for about five percent of what are known as major neurocognitive disorders. They are even more common among people with dementia that began before age 65. Among the ways that FTD can present, three important syndromes will be described here: behavioral variant frontotemporal dementia [FTD(bv)], language variant FTD [FTD(lv)], and amyotrophic lateral sclerosis with FTD [ALS/FTD].
Behavioral Variant of Frontotemporal Dementia
Richard’s condition was FTD(bv), a behavioral variant of frontotemporal dementia, and his symptom presentation initially looked like mania. Similar to a person with mania, Richard was energetic, impulsive and dysregulated. Richard’s lack of conformity with social norms was accompanied by aggressive outbursts and unusual lack of empathy and loss of concern for others. Others with his condition might also show neglect of their work or appearance, compulsive or repetitive behaviors, changes in eating habits or diet, ingestion of inedible objects, poor decision-making, vulnerability to scams or poor financial decisions, disorganization, agitation, or violent behavior. Lack of insight can be notable. In some people with behavioral variant FTD, apathy, and loss of initiative are more prominent than activation and disinhibition. Apathy can easily be mistaken for depression at first, but often is not accompanied by sadness, crying, loss of enjoyment, or suicidal thoughts and behaviors.
Language Variant of Frontotemporal Dementia
Marilyn’s condition was FTD(lv), a language variant of frontotemporal dementia, and this type of FTD typically appears in one of three forms. Her semantic dementia destroyed her understanding of the meaning of words even though she remained able to produce speech and repeat sentences. Over time, the person with semantic dementia may speak more vaguely or omit words. They can have trouble remembering the names of objects. Eventually, memory and behavior problems can also be seen.
Two other forms of FTD(lv) are described: non-fluent aphasia features a progressive difficulty producing the lip and tongue movements required in order to speak. Speech becomes effortful, slow, and ungrammatical. Instead of producing normal complicated sentences, the person with non-fluent aphasia often speaks in short phrases, missing the connecting prepositions and including wrong words. Understanding of single words is preserved, but long sentences are likely to be overwhelming. Eventually, language expression may be completely lost, resulting in muteness. In the logopenic variant, people have trouble finding words and speak more hesitantly as they search for the correct word. They are able to understand the meaning of words and their speech is not labored. Repetition is difficult for them and they sometimes substitute meaningless sounds for words.
Amyotrophic Lateral Sclerosis with Frontotemporal Dementia
Tom’s illness was clearly not simply a psychiatric depression because depression does not include muscle weakness and fasciculations. Evaluation of his nerve conduction velocity and neuropsychological status revealed that he had frontotemporal dementia along with disease of the motor cortex brain cells, the neurons that control muscles. This is one way that amyotrophic lateral sclerosis (ALS) can present. When FTD and motor neuron disease are both present, a person can develop muscle weakness leading to difficulty walking, grasping a pen, lifting their arms over their head, or performing precise small muscle movements. Physical examination reveals muscle twitching, spasticity, and atrophy as well as weakness. Over time, difficulty with speech and swallowing can be noticed.
As yet, we have no definitive treatment for FTD, but there are valuable information resources for caregivers and patients through the Association for Frontotemporal Dementia (AFTD).
Symptom-oriented medication treatment can be used to help with apathy, depression, mania, agitation, irritability, aggression, or delusions. Cognitive rehabilitation and speech therapy may address some language and swallowing difficulties.
Unlike Alzheimer’s disease, which typically begins with memory disturbance, FTD is a dementia in which behavior and language are first to show dramatic changes. Early recognition can assist patients and caregivers in the difficult journey associated with FTD. In time, we hope that research will identify disease-modifying or preventive treatments.
- Alzheimer’s Disease Toolkit (Helpful Information to Understand and Manage Alzheimer's Disease)
- Expert Information on Alzheimer's Disease (Articles)
- Frontotemporal Dementias (Article)
- Signs and Symptoms of Alzheimer’s Disease (Article)
- What is Dementia? (Article)
- What Causes Dementia? (Article)
- Riedl L, Mackenzie IR, Forstl H, et al. Frontotemporal lobar degeneration: current perspectives. Neuropsychiatr Dis Treat 2014 Feb 13;10:297-310. doi: 10.2147/NDT.S38706. eCollection 2014.Modified from McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia and Pick’s Disease. Arch Neurol 2001;58:1803-9.
- Saxon, J.A., Thompson, J.C., Jones, M. et al. Examining the language and behavioral profile in FTD and ALS-FTD. J. Neurol. Neurosurg. Psychiatry. June 2017.
This content was last updated on: June 10, 2019
The information provided here is a public service of the BrightFocus Foundation and should not in any way substitute for personalized advice of a qualified healthcare professional; it is not intended to constitute medical advice. Please consult your physician for personalized medical advice. BrightFocus Foundation does not endorse any medical product, therapy, or resources mentioned or listed in this article. All medications and supplements should only be taken under medical supervision. Also, although we make every effort to keep the medical information on our website updated, we cannot guarantee that the posted information reflects the most up-to-date research.
These articles do not imply an endorsement of BrightFocus by the author or their institution, nor do they imply an endorsement of the institution or author by BrightFocus.
Some of the content may be adapted from other sources, which will be clearly identified within the article.